Simultaneous screening and quantification of 25 opioid drugs in post-mortem blood and urine by liquid chromatography-tandem mass spectrometry

Forensic Science International

Volumn 186, Issue 1-3, 2009, Pages 36-43

  Gergov, M ^a   Nokua, P ^a   Vuori, E ^a   Ojanpera I ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Fentanyls; LC MS MS; Opioid drugs

Indexed keywords

4 FLUOROFENTANYL; ACETONITRILE; ALFENTANIL; ALPHA METHYLFENTANYL; AMMONIUM ACETATE; BUPRENORPHINE; CODEINE; DEXTROPROPOXYPHENE; DIAMORPHINE; ETHYLMORPHINE; FENTANYL; FENTANYL DERIVATIVE; HEXANOIC ACID; MEFENTANYL; METHADONE; MORPHINE; MORPHINE 6 ACETATE; NALOXONE; NALTREXONE; NORBUPRENORPHINE; NORFENTANYL; NORMETHADONE; OPIATE; OXYCODONE; PENTAZOCINE; PETHIDINE; REMIFENTANIL; SUFENTANIL; TRAMADOL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACCURACY; ANALYTIC METHOD; ARTICLE; AUTOPSY; CONCENTRATION (PARAMETERS); DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; DRUG SCREENING; DRUG URINE LEVEL; HUMAN; ION TRAP MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; PH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; TECHNIQUE; VALIDITY;

EID: 62549116527     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2009.01.013     Document Type: Article

References (45)

1. Van Bever W.F.M., Niemegeers C.J.E., and Janssen P.A.J. Synthetic analgesics. synthesis and pharmacology of the diastereoisomers of N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide and N-[3-ethyl-1-(1-methyl-2-phenylethy1)-4-piperidyl]-N-phenylpropanamide. J. Med. Chem. 17 (1974) 1047-1051
2. Stanley T. Human immobilization: is the experience in Moscow just the beginning [Editorial]. Eur. J. Anaesthesiol. 20 (2003) 427-428
3. Mao C.-L., Zientek K.D., Colahan P.T., Kuo M.-Y., Liu C.-H., Lee K.-M., and Chou C.-C. Development of an enzyme-linked immunosorbent assay for fentanyl and applications of fentanyl antibody-coated nanoparticles for sample preparation. J. Pharm. Biomed. Anal. 41 (2006) 1332-1341
4. Bagheri H., Es-Haghi A., Khalilian F., and Rouini M.-R. Determination of fentanyl in human plasma by head-space solid-phase microextraction and gas chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 43 (2007) 1763-1768
5. Van Nimmen N.J.F., Poels K.L.C., and Veulemans H.A.F. Highly sensitive gas chromatographic-mass spectrometric screening method for the determination of picogram levels of fentanyl, sufentanil and alfentanil and their major metabolites in urine of opioid exposed workers. J. Chromatogr. B 804 (2004) 375-387
6. Paradis C., Dufresne C., Bolon M., and Boulieu R. Solid-phase microextraction of human plasma samples for determination of sufentanil by gas chromatography-mass spectrometry. Ther. Drug Monit. 24 (2002) 768-774
7. Dufresne C., Favetta P., Gonin R., and Bureau J. Simultaneous determination of fentanyl and midazolam in plasma using direct solid-phase microextraction before gas chromatography-mass spectrometry analysis. J. Guitton, Anal. Lett. 35 (2002) 1575-1590
8. Coopman V., Cordonnier J., Pien K., and Van Varenbergh D. LC-MS/MS analysis of fentanyl and norfentanyl in a fatality due to application of multiple durogesic transdermal therapeutic systems. Forensic Sci. Int. 139 (2007) 223-227
9. Bossu E., Montinaro A., Lecce R., Farina A., Suppa E., Draisci G., and Gostoli G. LC-MS determination of remifentanil in maternal and neonatal plasma. J. Pharm. Biomed. Anal. 42 (2006) 367-371
10. Huynh N.-H., Tyrefors N., Ekman L., and Johansson M. Determination of fentanyl in human plasma and fentanyl and norfentanyl in human urine using LC-MS/MS. J. Pharm. Biomed. Anal. 37 (2005) 1095-1100
11. Thevis M., Geyer H., Bahr D., and Schaenzer W. Identification of fentanyl, alfentanil, sufentanil, remifentanil and their major metabolites in human urine by liquid chromatography/tandem mass spectrometry for doping control purposes. Eur. J. Mass Spectrom. 11 (2005) 419-427
12. Koch D.E., Isaza R., Carpenter J.W., and Hunter R.P. Simultaneous extraction and quantitation of fentanyl and norfentanyl from primate plasma with LC/MS detection. J. Pharm. Biomed. Anal. 34 (2004) 577-584
13. Day J., Slawson M., Lugo R.A., and Wilkins D. Analysis of fentanyl and norfentanyl in human plasma by liquid chromatography-tandem mass spectrometry using electrospray ionization. J. Anal. Toxicol. 27 (2003) 513-516
14. Palleschi L., Lucentini L., Ferretti E., Anastasi F., Amoroso M., and Draisci G. Quantitative determination of sufentanil in human plasma by liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 32 (2003) 329-336
15. Martens-Lobenhoffer J. Very sensitive and specific determination of sufentanil in human serum applying liquid chromatography-two stage mass spectrometry. J. Chromatogr. B 769 (2002) 227-233
16. Shou W.Z., Jiang X., Beato B.D., and Naidong W. A highly automated 96-well solid phase extraction and liquid chromatography/tandem mass spectrometry method for the determination of fentanyl in human plasma. Rapid Commun. Mass Spectrom. 15 (2001) 466-476
17. Wang L., and Bernert J.T. Analysis of 13 fentanils, including sufentanil and carfentanil, in human urine by liquid chromatography-atmospheric-pressure ionization-tandem mass spectrometry. J. Anal. Toxicol. 30 (2006) 335-341
18. Chen B.-G., Wang S.-M., and Liu R.H. GC-MS analysis of multiply derivatized opioids in urine. J. Mass Spectrom. 42 (2007) 1012-1023
19. Meatherall R. GC-MS quantitation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in blood. J. Anal. Toxicol. 29 (2005) 301-308
20. ® automated solid-phase extraction and gas chromatography-mass spectrometry. J. Chromatogr. B 822 (2005) 137-145
21. Ropero-Miller J.D., Lambing M.K., and Winecker R.E. Simultaneous quantitation of opioids in blood by GC-EI-MS analysis following deprotonation, deautomerization of keto analytes, solid-phase extraction, and trimethylsilyl derivatization. J. Anal. Toxicol. 26 (2002) 524-528
22. Coles R., Kushnir M.M., Nelson G., McMillin G., and Urry F.M. Simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, oxycodone, and 6-acetylmorphine in urine, serum, plasma, whole blood, and meconium by LC-MS-MS. J. Anal. Toxicol. 31 (2007) 1-14
23. Gustavsson E., Andersson M., Stephanson N., and Beck O. Validation of direct injection electrospray LC-MS/MS for confirmation of opiates in urine drug testing. J. Mass Spectrom. 42 (2007) 881-889
24. Svensson J.-O., Andersson M., Gustavsson E., and Beck O. Electrospray LC-MS method with solid-phase extraction for accurate determination of morphine-, codeine-, and ethylmorphine-glucuronides and 6-acetylmorphine in urine. J. Anal. Toxicol. 31 (2007) 81-86
25. Musshoff F., Trafkowski J., Kuepper U., and Madea B. An automated and fully validated LC-MS/MS procedure for the simultaneous determination of 11 opioids used in palliative care, with 5 of their metabolites. J. Mass Spectrom. 41 (2006) 633-640
26. Edinboro L.E., Backer R.C., and Poklis A. Technical note: direct analysis of opiates in urine by liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 29 (2005) 704-710
27. Al-Asmari A.I., and Anderson R.A. Method for quantification of opioids and their metabolites in autopsy blood by liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 31 (2007) 394-408
28. Rasanen I., Kontinen I., Nokua J., Ojanperä I., and Vuori E. Precise gas chromatography with retention time locking in comprehensive toxicological screening for drugs in blood. J. Chromatogr. B 788 (2003) 243-250
29. Scislowski M., Piekoszewski W., Kamenczak A., and Florek E. Simultaneous determination of buprenorphine and norbuprenorphine in serum by high-performance liquid chromatography-electrospray ionization mass spectrometry. J. Anal. Toxicol. 29 (2005) 249-253
30. Ceccato A., Klinkenberg R., Huber B., and Streel B. Sensitive determination of buprenorphine and its N-dealkylated metabolite norbuprenorphine in human plasma by liquid chromatography coupled to tandem mass spectrometry. J. Pharm. Biomed. Anal. 32 (2003) 619-631
31. Polettini A., and Huestis M.A. Simultaneous determination of buprenorphine, norbuprenorphine, and buprenorphine-glucuronide in plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 754 (2001) 447-459
32. Baselt R.C. Disposition of Toxic Drugs and Chemicals in Man (2004), Biomedical Publications, Foster City, CA p. 727
33. Uges D.R.A. Therapeutic and toxic drug concentrations. Bull. Int. Assoc. Forensic Toxicol. 26 (1 supplement) (1996) 1-34
34. Schulz M., and Schmoldt A. Therapeutic and toxic blood concentrations of more than 500 drugs. Pharmazie 52 (1997) 895-911
35. Osselton M.D. Toxicological tables: a compendium of pharmacological, therapeutic and toxicological data on 136 drugs and chemicals on humans. Bull. Int. Assoc. Forensic Toxicol. 17 (1983) 16-33
36. In: Jack D.B. (Ed). Handbook of Clinical Pharmacokinetic Data (1992), Macmillan, Hants p. 5
37. Meyer F.P. Indicative therapeutic and toxic drug concentrations in plasma: a tabulation. Int. J. Clin. Pharm. Ther. 32 (1994) 71-81
38. Winek C.L., Wahba W.W., Winek Jr. C.L., and Winek-Balzer T. Drug and chemical blood-level data 2001. Forensic Sci. Int. 122 (2001) 107-123
39. Stead A.H., and Moffat A.C. A collection of therapeutic toxic and fatal blood drug concentrations in man. Human Toxicol. 3 (1983) 437-464
40. TIAFTnet 2007 (The Association of Forensic Toxicologists), URL http://www.tiaft.org
41. Matuszewski B.K., Constanzer M.L., and Chavez-Eng C.M. Matrix effects in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations. Anal. Chem. 70 (1998) 882-889
42. Matuszewski B.K., Constanzer M.L., and Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 75 (2003) 3019-3030
43. Mallet C.R., Lu Z., and Mazzeo J.R. A study of ion suppression effects in electrospray ionization from mobile phase additives and solid phase extracts. Rapid Commun. Mass Spectrom. 18 (2004) 49-58
44. Annesley T.M. Ion suppression in mass spectrometry. Clin. Chem. 49 (2003) 1041-1044
45. Liang H.R., Foltz R.L., Meng M., and Bennett P. Ionization enhancement in atmospheric pressure chemical ionization and suppression in electrospray ionization between target drugs and stable-isotope-labelled internal standards in quantitative liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 17 (2003) 2815-2821